NCT00435253View on ClinicalTrials.gov

US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Pulmonary Emphysema
Interventions
BIOLOGICAL

BLVR Treatment

BLVR Treatment, 10 mL Hydrogel

Trial Locations (5)

29425

Medical University of South Carolina Hospital, Charleston

35249

University of Alabama Birmingham Lung Health Center, Birmingham

85006

Pulmonary Associates, Phoenix

02135

Caritas St Elizabeth's Med Cen, Boston

01940

Temple University Lung Center, Philadelphia

Sponsors

Lead Sponsor

Aeris Therapeutics
All Listed Sponsors
lead

Aeris Therapeutics

INDUSTRY

NCT00435253 - US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study | Biotech Hunter | Biotech Hunter